Dominant Sensitive Genes Antibiotics by Phage-Mediated Delivery of Reversing Bacterial Resistance to
暂无分享,去创建一个
[1] D. Drecktrah,et al. Use of rpsL as a Counterselectable Marker in Borrelia burgdorferi , 2009, Applied and Environmental Microbiology.
[2] E. Änggård,et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[3] Timothy K Lu,et al. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.
[4] D. Court,et al. Recombineering: a homologous recombination-based method of genetic engineering , 2009, Nature Protocols.
[5] R. Hancock,et al. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.
[6] D. Zannoni,et al. The bacterial response to the chalcogen metalloids Se and Te. , 2008, Advances in microbial physiology.
[7] I. Sugawara,et al. Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. , 2007, Microbes and infection.
[8] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[9] L. Lang. FDA approves use of bacteriophages to be added to meat and poultry products. , 2006, Gastroenterology.
[10] H. Brüssow,et al. Phage therapy: the Escherichia coli experience. , 2005, Microbiology.
[11] Jian-Dong Huang,et al. Efficient and seamless DNA recombineering using a thymidylate synthase A selection system in Escherichia coli , 2005, Nucleic acids research.
[12] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[13] H. Steingrimsdottir,et al. Mutant sequences in the rpsL gene of Escherichia coli B/r: Mechanistic implications for spontaneous and ultraviolet light mutagenesis , 1992, Molecular and General Genetics MGG.
[14] D. Hughes,et al. Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections , 2003, Antimicrobial Agents and Chemotherapy.
[15] C. Merril,et al. The prospect for bacteriophage therapy in Western medicine , 2003, Nature Reviews Drug Discovery.
[16] J. Claverys,et al. An rpsL Cassette, Janus, for Gene Replacement through Negative Selection in Streptococcus pneumoniae , 2001, Applied and Environmental Microbiology.
[17] Characterization of gram-positive tellurite resistance encoded by the Streptococcus pneumoniae tehB gene. , 1999, FEMS microbiology letters.
[18] J. Musser,et al. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities , 1996, Antimicrobial agents and chemotherapy.
[19] N. Robillard. Broad-host-range gyrase A gene probe , 1990, Antimicrobial Agents and Chemotherapy.
[20] Henry Huang,et al. Homologous recombination in Escherichia coli: dependence on substrate length and homology. , 1986, Genetics.
[21] M. Lieb. Ultraviolet Sensitivity of Escherichia coli Containing Heat-Inducible λ Prophages , 1964, Science.
[22] M. Lieb. ULTRAVIOLET SENSITIVITY OF ESCHERICHIA COLI CONTAINING HEAT-INDUCIBLE LAMBDA PROPHAGES. , 1964, Science.
[23] J. Lederberg. STREPTOMYCIN RESISTANCE: A GENETICALLY RECESSIVE MUTATION , 1951, Journal of bacteriology.